SINT Overview

SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.

Wall Street analysts forecast SINT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SINT is16.00 USD with a low forecast of 16.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

SINTX Technologies Inc revenue for the last quarter amounts to 208.00K USD, decreased -73.97

SINTX Technologies Inc. EPS for the last quarter amounts to -3.46 USD, decreased -50.29

SINTX Technologies Inc (SINT) has 20 emplpoyees as of March 21 2026.

Today SINT has the market capitalization of 9.94M USD.